China Universal Asset Management Company’s Applied Therapeutics APLT Stock Holding History

China Universal Asset Management Company’s Portfolio APLT Stock Details APLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-25,243	Closed	-$15.3K	–	503
2025 Q3	$15.3K	Sell	25,243 -3,192	-11%	-$1.5K	﹤0.01%	466
2025 Q2	$8.85K	Buy	28,435 +5,096	+22%	+$1.97K	﹤0.01%	466
2025 Q1	$11.4K	Sell	23,339 -1,333	-5%	-$785	﹤0.01%	475
2024 Q4	$21.1K	Buy	+24,672	New	+$155K	﹤0.01%	483
2022 Q4	–	Sell	-450	Closed	–	–	397
2022 Q3	$0	Buy	+450	New	+$540	﹤0.01%	438

Other funds holding APLT

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

DAM

Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

China Universal Asset Management Company's APLT Position: Q4 2025 in Review

China Universal Asset Management Company sold out of Applied Therapeutics (APLT) in Q4 2025, closing a stake of 25,243 shares — an estimated $15.3K sold.

China Universal Asset Management Company first reported a position in APLT in Q3 2022 and held it in 5 quarters. The position peaked at $21.1K in Q4 2024. 52 funds tracked by Wall St. Rank hold APLT as of Q4 2025.

China Universal Asset Management Company reported no remaining Applied Therapeutics position as of Q4 2025 after selling out during the quarter.
China Universal Asset Management Company sold 25,243 Applied Therapeutics shares in Q4 2025, an estimated $15.3K.
China Universal Asset Management Company first reported a position in Applied Therapeutics in Q3 2022 and held it in 5 quarters.
China Universal Asset Management Company's Applied Therapeutics position peaked at $21.1K in Q4 2024.
52 funds tracked by Wall St. Rank held Applied Therapeutics as of Q4 2025.

Based on China Universal Asset Management Company's 13F filing for Q4 2025, filed 29 Jan 2026.